相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells
Elisa Burgos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Evidence That Spinal Astrocytes but Not Microglia Contribute to the Pathogenesis of Paclitaxel-Induced Painful Neuropathy
Haijun Zhang et al.
JOURNAL OF PAIN (2012)
Interleukin-6, a mental cytokine
Anneleen Spooren et al.
BRAIN RESEARCH REVIEWS (2011)
PROTEINASE-ACTIVATED RECEPTOR 2 SENSITIZES TRANSIENT RECEPTOR POTENTIAL VANILLOID 1, TRANSIENT RECEPTOR POTENTIAL VANILLOID 4, AND TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1 IN PACLITAXEL-INDUCED NEUROPATHIC PAIN
Y. Chen et al.
NEUROSCIENCE (2011)
Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers
Bal L. Lokeshwar
PHARMACOLOGICAL RESEARCH (2011)
Antimicrobial and non-antimicrobial tetracyclines in human cancer trials
Christopher Richards et al.
PHARMACOLOGICAL RESEARCH (2011)
Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase
Ying Gu et al.
PHARMACOLOGICAL RESEARCH (2011)
Prevention of Paclitaxel-induced allodynia by Minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats
Cui-Cui Liu et al.
MOLECULAR PAIN (2010)
Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain
Willias Masocha
JOURNAL OF NEUROIMMUNOLOGY (2009)
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity
Noelle Callizot et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Up-regulation of matrix metalloproteinase-3 in the dorsal root ganglion of rats with paclitaxel-induced neuropathy
Kentaro Nishida et al.
CANCER SCIENCE (2008)
Glia in pathological pain: A role for fractalkine
E. D. Milligan et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice
Francisco Rafael Nieto et al.
PAIN (2008)
An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat
Christopher M. Peters et al.
BRAIN RESEARCH (2007)
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats
Annemarie Ledeboer et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: An AIDS Malignancy Consortium study
BJ Dezube et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines
Y Gu et al.
ANNALS OF MEDICINE (2005)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients
PM Dougherty et al.
PAIN (2004)
Is chronic pain a distinct diagnosis in primary care? Evidence arising from the Royal College of General Practitioners' Oral Contraception study
BH Smith et al.
FAMILY PRACTICE (2004)
Chemically modified tetracyclines as inhibitors of matrix metalloproteinases
MR Acharya et al.
DRUG RESISTANCE UPDATES (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Chemotherapy-evoked painful peripheral neuropathy
RC Polomano et al.
PAIN MEDICINE (2001)
分享论文
